Skip to main content
European Commission logo print header

Early clinical diagnosis of human spongiform encephalopathies by analysis of biological fluids (CJD MARKERS)

Objetivo

The introduction of biochemical parameters (proteins such as 14-3-3, NSE, S 100 and taut) has led to the improvement of the clinical 1 diagnosis of CJD. In the differential diagnosis of neurodegenerative disorders, elevated levels in the cerebrospinal fluid (CSF) support the diagnosis with sensitivity and specificity of and 93%. However, some disease phenotypes (such as variant CJD, sporadic CJD with MV-2 phenotype and genetic cases) are negative for, those parameters. The proposed study will cover the work on further biochemical parameters (surrogate markers) of the disease. A set of parameters for early diagnosis during lifetime will be established. Another aspect of the proposed study will cover the detection methodology of disease-specific infected protein in biological fluids such as CSF, serum, plasma and urine using capillary electrophoresis. A sample bank from patients with CJD, other dementia and normal controls will be established.

Convocatoria de propuestas

Data not available

Coordinador

FACULTY OF MEDICINE/UNIVERSITY HOSPITAL GOETTINGEN
Aportación de la UE
Sin datos
Dirección
Robert-Koch-Strasse 40
37075 GOETTINGEN
Alemania

Ver en el mapa

Coste total
Sin datos

Participantes (9)